Literature DB >> 15127080

Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?

Eugenii A Rabiner1, Zubin Bhagwagar, Roger N Gunn, Philip J Cowen, Paul M Grasby.   

Abstract

Using positron emission tomography and the selective 5-HT1A receptor radioligand [11C]WAY100635, we previously demonstrated a preferential occupancy of 5-HT1A autoreceptors, compared to postsynaptic receptors by pindolol in healthy volunteers. We have speculated that preferential occupancy may be clinically important for the purported actions of pindolol in accelerating the antidepressant effects of selective serotonin re-uptake inhibitors (SSRIs). In this study, we have examined the preferential occupancy by pindolol of 5-HT1A autoreceptors, following three different pindolol regimes (10 mg single dose, 2.5 mg t.i.d., and 5 mg t.i.d., in 15 depressed patients on SSRIs. In addition, seven healthy volunteers were examined following a single 10 mg dose of pindolol. We found a preferential occupancy of 22.6+/-7.7% following a single dose of 10 mg of pindolol, in the healthy volunteers, which was attenuated in depressed patients on the same dose of pindolol to 2.9+/-10.8% (Student's t=3.94, df=12, p=0.002). In addition, we found a significant negative correlation between the degree of preferential occupancy and the severity of depression as assessed by the Hamilton depression rating score (HAM-D), Spearman's rho=-0.728, N=14, p=0.003, in the depressed sample. A possible mechanism underlying preferential occupancy and the attenuation of this phenomenon in depressed patients on SSRIs may include changes in the proportion of high affinity 5-HT1A sites in the autoreceptor region of the midbrain raphe. Speculatively, the degree of preferential occupancy may serve as a surrogate marker for depression, or the pharmacological effects of antidepressants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127080     DOI: 10.1038/sj.npp.1300472

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

Review 1.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

2.  The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.

Authors:  Marleen Wingen; Kim P C Kuypers; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2006-11-24       Impact factor: 4.530

3.  Opposing actions of 5HT1A and 5HT2-like serotonin receptors on modulations of the electric signal waveform in the electric fish Brachyhypopomus pinnicaudatus.

Authors:  Susan J Allee; Michael R Markham; Vielka L Salazar; Philip K Stoddard
Journal:  Horm Behav       Date:  2007-12-14       Impact factor: 3.587

4.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

Review 5.  Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.

Authors:  Paul R Albert; Brice Le François; Anne M Millar
Journal:  Mol Brain       Date:  2011-05-27       Impact factor: 4.041

6.  Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist.

Authors:  Hong-xia Chen; Zeng-liang Jin; Li-ming Zhang; Rui Xue; Xiao-dan Xu; Nan Zhao; Zhi-kun Qiu; Xian-wang Wang; You-zhi Zhang; Ri-fang Yang; Yun-feng Li
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.